Replies to post #205293 on Biotech Values

[Giovanni]

is CMX157 side effect profile better then TAF?
or the same?

Thanks

[biomaven0]

>>CMX157 and TAF have the same active ingredient (tenofovir), and both requires a much lower dose than Viread to generate Viread-equivalent efficacy.

From what I know (which admittedly isn't much) the CMX drug concentrates in the liver. So they have at least a shot at a better therapeutic ratio for HBV.